Recruiting

Cavity Marking

Sponsor:

University of Florida

Code:

NCT06903468

Conditions

Ductal Carcinoma in Situ

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Novel cavity marking technique

Study Details

Brief summary:

This study will investigate a novel approach to marking surgical cavity margins following tumor resection, to allow for more accurate radiotherapy following oncoplastic surgery. Our proposed cavity marking schema will allow radiation oncology to identify the cavity margins more accurately on CT simulation for radiation planning and delivery. This cavity marking schema also provides more accurate margin identification in patients recommended for re-excision of close or positive margins.

Conditions

Ductal Carcinoma in Situ

Breast Cancer

Study ID

NCT06903468

Start date

Oct 27, 2025

Status verified date

Dec, 2025

Completion date

Nov, 2029

Anticipated

Primary completion date

Nov, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Adults ≥ 18 years of age.
  • A pathological diagnosis consistent with non-invasive ductal carcinoma in-situ (DCIS) and invasive breast cancer, Tis-T3N0-3M0
  • Subject is planning to undergo or has undergone breast conservation surgery and oncoplastic reconstruction with cavity marking surgery.
  • ECOG Performance status of 0-1
  • Written informed consent obtained from the subject and the subject agrees to comply with all the study-related procedures.
  • Subjects must not have more than one active malignancy at the time of enrollment (Subjects with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen \[as determined by the treating physician or approved by the PI\] may be included).
  • Subjects of childbearing potential (SOCBP) must be using an adequate method of contraception to avoid pregnancy during surgery and radiation therapy. Prior to study enrollment, subjects of childbearing potential must be advised of the importance of avoiding pregnancy during the surgery and radiation portions of the trial and the potential risk factors for an unintentional pregnancy. SOCBP includes any subject who has experienced menarche and who has not undergone successful surgical sterilization (hysterectomy, bilateral tubal ligation, or bilateral oophorectomy) or who is not post-menopausal. Post-menopause is defined as amenorrhea that has lasted for ≥ 12 consecutive months without another cause.

Exclusion Criteria:

  • Patient not recommended for, or have declined, adjuvant radiotherapy
  • Subjects with prior ipsilateral breast surgery and identifiable surgical clips.
  • Subjects who are confirmed to be pregnant or breastfeeding.
  • History of any other disease, metabolic dysfunction, clinical examination finding, or clinical laboratory finding giving reasonable suspicion of a disease or condition that contraindicates the use of protocol therapy or that might affect the interpretation of the results of the study or that puts the subject at high risk for treatment complications, in the opinion of the treating physician.
  • Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detailed for treatment of either a psychiatric or physical illness.

Study Design

Enrollment

50 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Novel cavity marking technique during breast conservation surgery with oncoplastic reconstruction

Interventions

Novel cavity marking technique

A novel cavity marking technique will be performed on all participants during their breast conservation surgery. For this technique, cavity marking will be in a clockwise fashion per breast starting with the superior margin of the tumor bed. The superior margin of the left breast will be marked with a single large clip, followed by a double clip for the lateral margin, a triple clip for the inferior margin, and a quadruple clip for the medial margin. The superior margin of the right breast will be marked with a single large clip, followed by a double clip for the medial margin, a triple clip for the inferior margin and a quadruple clip for the lateral margin. Margins with multiple clips will always have one large clip with the remaining clips standard medium size.

Primary outcome measure

  • Confidence rating in cavity identification [ Time Frame: Within 8 weeks of surgery if patient does not receive adjuvant chemotherapy or within 8 weeks following adjuvant chemotherapy (~4-6 months after surgery ]

Central Contacts and Locations

Central contacts

Madeline Campellone

352-273-5128mcampellone@ufl.edu

Laura J Mallinson

(352) 265-5125coppola@ufl.edu

Locations

University of Florida

Recruiting

Gainesville, Florida, United States, 32608

Contacts

Madeline Campellone

352-273-5128mcampellone@ufl.edu

Laura J Mallinson

(352) 265-5125coppola@ufl.edu

Principal Investigator:

Lisa Spiguel, MD

More Information

Sponsor

University of Florida

Last update posted

Sep 9, 2026

Last verified

Dec, 2025

Keywords

  • invasive breast cancer
  • non-invasive ductal carcinoma in-situ
  • oncoplastic reconstruction
  • breast conservation surgery
  • boost volume
  • cavity marking
  • breast

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Florida on 2026-09-09.